Literature DB >> 11940059

The role of COX-1 and COX-2 in asthma pathogenesis and its significance in the use of selective inhibitors.

A Szczeklik, M Sanak.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11940059     DOI: 10.1046/j.1365-2222.2002.01333.x

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN: 0954-7894            Impact factor:   5.018


× No keyword cloud information.
  6 in total

1.  Aspirin-exacerbated asthma.

Authors:  Mathew Varghese; Richard F Lockey
Journal:  Allergy Asthma Clin Immunol       Date:  2008-06-15       Impact factor: 3.406

2.  Prostaglandin-endoperoxide synthase genes COX1 and COX2 - novel modifiers of disease severity in cystic fibrosis patients.

Authors:  K Czerska; A Sobczynska-Tomaszewska; D Sands; A Nowakowska; D Bak; K Wertheim; J Poznanski; J Zielenski; A Norek; J Bal
Journal:  J Appl Genet       Date:  2010       Impact factor: 2.653

Review 3.  Aspirin Intolerance: Experimental Models for Bed-to-Bench.

Authors:  Masamichi Yamashita
Journal:  Curr Drug Targets       Date:  2016       Impact factor: 3.465

4.  Dynamic model of eicosanoid production with special reference to non-steroidal anti-inflammatory drug-triggered hypersensitivity.

Authors:  Aleš Fajmut; Tadej Emeršič; Andrej Dobovišek; Nataša Antić; Dirk Schäfer; Milan Brumen
Journal:  IET Syst Biol       Date:  2015-10       Impact factor: 1.615

Review 5.  Samter's Triad: State of the Art.

Authors:  Sung-Dong Kim; Kyu-Sup Cho
Journal:  Clin Exp Otorhinolaryngol       Date:  2018-04-13       Impact factor: 3.372

6.  Expression of COX-1, COX-2, 5-LOX and CysLT 2 in nasal polyps and bronchial tissue of patients with aspirin exacerbated airway disease.

Authors:  Monique Vorsprach; Christoph Arens; Stephan Knipping; Dörte Jechorek; Sabine Stegemann-Koniszewski; Eva Lücke; Jens Schreiber
Journal:  Allergy Asthma Clin Immunol       Date:  2019-12-26       Impact factor: 3.406

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.